PMID- 38023618 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231201 IS - 1687-9627 (Print) IS - 1687-9635 (Electronic) VI - 2023 DP - 2023 TI - Cytomegalovirus Infection in Patient with Clear Cell Renal Cell Carcinoma. PG - 5560673 LID - 10.1155/2023/5560673 [doi] LID - 5560673 AB - INTRODUCTION: Cytomegalovirus (CMV) infection is a widespread condition that can affect individuals of all ages. Most cases of CMV infection are mild and resolve on their own. However, in immunocompromised individuals, such as post-transplant patients or those with cancer, severe infections can occur. While there have been several studies on CMV infection in post-transplant patients, there is limited literature on CMV infection in cancer, particularly in kidney cancer. Case Report. In this case report, we present the case of a 61-year-old man with clear cell renal cell carcinoma who underwent targeted therapy with the receptor tyrosine kinase (RTK) inhibitor lenvatinib and the mammalian target of rapamycin (mTOR) inhibitor everolimus. The patient was hospitalized for 26 days and admitted to the intensive care unit (ICU) due to shortness of breath, decreased oxygen saturation, and irregular breathing. Cytomegalovirus polymerase chain reaction (PCR) test results were positive. Given the high prevalence of CMV infection in developing countries, it is likely that the patient had a reactivation of CMV. As such, the patient was subsequently treated with ganciclovir for 14 days and showed improvement in symptoms such as shortness of breath, cough, fever, and increased oxygen saturation. Following recovery, the patient received maintenance therapy with oral valganciclovir for 7 days. No further symptoms appeared during subsequent cancer treatments. CONCLUSION: Cancer patients who are undergoing treatment are at a higher risk for developing opportunistic infections, which can result in morbidity and mortality. Therefore, healthcare professionals should be aware of the possibility of CMV infection in cancer patients and be prepared to diagnose and treat the infection, particularly in areas where the prevalence of CMV infection is high. CI - Copyright (c) 2023 Ikhwan Rinaldi et al. FAU - Rinaldi, Ikhwan AU - Rinaldi I AUID- ORCID: 0000-0002-6872-8802 AD - Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. FAU - Muthalib, Abdul AU - Muthalib A AD - Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. FAU - Sutandar, Januar Widodo AU - Sutandar JW AD - Department of Internal Medicine, Gading Pluit Hospital, Jakarta, Indonesia. FAU - Kuncoro, Hendro Adi AU - Kuncoro HA AD - Department of Cardiology, Gading Pluit Hospital, Jakarta, Indonesia. FAU - Harsono, Bambang Irawan AU - Harsono BI AD - Department of Pulmonology, Gading Pluit Hospital, Jakarta, Indonesia. FAU - Susanto, Nelly AU - Susanto N AD - Department of Radiology, Gading Pluit Hospital, Jakarta, Indonesia. FAU - Setiawan, Tjondro AU - Setiawan T AD - Department of Radiology, Gading Pluit Hospital, Jakarta, Indonesia. FAU - Winston, Kevin AU - Winston K AUID- ORCID: 0000-0003-2667-1999 AD - Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. FAU - Dewantara, Idham Rafly AU - Dewantara IR AUID- ORCID: 0000-0002-2594-541X AD - Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. FAU - Amin, Ihya Fakhrurizal AU - Amin IF AUID- ORCID: 0000-0002-2024-9650 AD - Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. FAU - Shufiyani, Yuli Maulidiya AU - Shufiyani YM AUID- ORCID: 0009-0005-9487-3527 AD - Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. LA - eng PT - Case Reports DEP - 20231113 PL - United States TA - Case Rep Med JT - Case reports in medicine JID - 101512910 PMC - PMC10661874 COIS- The authors declare that they have no conflicts of interest. EDAT- 2023/11/29 18:42 MHDA- 2023/11/29 18:43 PMCR- 2023/11/13 CRDT- 2023/11/29 15:51 PHST- 2023/01/19 00:00 [received] PHST- 2023/08/08 00:00 [revised] PHST- 2023/10/25 00:00 [accepted] PHST- 2023/11/29 18:43 [medline] PHST- 2023/11/29 18:42 [pubmed] PHST- 2023/11/29 15:51 [entrez] PHST- 2023/11/13 00:00 [pmc-release] AID - 10.1155/2023/5560673 [doi] PST - epublish SO - Case Rep Med. 2023 Nov 13;2023:5560673. doi: 10.1155/2023/5560673. eCollection 2023.